UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Use of nucleoside reverse transcriptase inhibitors and risk of myocardial infarction in HIV-infected patients enrolled in the D:A:D study: a multi-cohort collaboration

The Lancet (British edition), 2008-04, Vol.371 (9622), p.1417-1426

2008

Volltextzugriff (PDF)

Prior exposure to thymidine analogs and didanosine is associated with long-lasting alterations in adipose tissue distribution and cardiovascular risk factors

AIDS (London), 2019-03, Vol.33 (4), p.675-683

2019

Volltextzugriff (PDF)

Ten-year diabetes incidence in 1046 HIV-infected patients started on a combination antiretroviral treatment

AIDS (London), 2012-01, Vol.26 (3), p.303-314

2012

Volltextzugriff (PDF)

Liver fibrosis in HIV-infected individuals on long-term antiretroviral therapy: associated with immune activation, immunodeficiency and prior use of didanosine

AIDS (London), 2016-07, Vol.30 (11), p.1771-1780

2016

Volltextzugriff (PDF)

PREVALENCE OF DIDANOSINE-RELATED RETINAL TOXICITY AT AN URBAN ACADEMIC CENTER AS DIAGNOSED WITH ULTRA-WIDEFIELD IMAGING

Retina (Philadelphia, Pa.), 2024-10, Vol.44 (10), p.1828

2024

Volltextzugriff (PDF)

Pericardial Adipose Tissue Volume Is Independently Associated With Human Immunodeficiency Virus Status and Prior Use of Stavudine, Didanosine, or Indinavir

The Journal of infectious diseases, 2020-06, Vol.222 (1), p.54-61

2020

Volltextzugriff (PDF)

Metabolic events in HIV-infected patients using abacavir are associated with erythrocyte inosine triphosphatase activity

Journal of antimicrobial chemotherapy, 2019-01, Vol.74 (1), p.157-164

2019

Volltextzugriff (PDF)

New-onset diabetes in HIV-treated adults: predictors, long-term renal and cardiovascular outcomes

AIDS (London), 2017-07, Vol.31 (11), p.1535-1543

2017

Volltextzugriff (PDF)

Tenofovir renal toxicity targets mitochondria of renal proximal tubules

Laboratory investigation, 2009-05, Vol.89 (5), p.513-519

2009

Volltextzugriff (PDF)

DIDANOSINE RETINAL TOXICITY

Retina (Philadelphia, Pa.), 2016-12, Vol.36 Suppl 1, p.S159

2016

Volltextzugriff (PDF)

Risk of cancer in children exposed to didanosine in utero

AIDS (London), 2016-05, Vol.30 (8), p.1245-1256

2016

Volltextzugriff (PDF)

Epidemiology and factors associated with peripheral neuropathy among HIV infected patients in Gondar, Ethiopia: A cross-sectional study

PloS one, 2019-01, Vol.14 (1), p.e0211354-e0211354

2019

Volltextzugriff (PDF)

Association of Noncirrhotic Portal Hypertension in HIV-Infected Persons and Antiretroviral Therapy with Didanosine: A Nested Case-Control Study

Clinical infectious diseases, 2009-08, Vol.49 (4), p.626-635

2009

Volltextzugriff (PDF)

Impact of NRTIs on lipid levels among a large HIV-infected cohort initiating antiretroviral therapy in clinical care

AIDS (London), 2011-01, Vol.25 (2), p.185-195

2011

Volltextzugriff (PDF)

Severe liver disease associated with prolonged exposure to antiretroviral drugs

Journal of acquired immune deficiency syndromes (1999), 2006-06, Vol.42 (2), p.177-182

2006

Volltextzugriff (PDF)

Association of serum lipid levels with HIV serostatus, specific antiretroviral agents, and treatment regimens

Journal of acquired immune deficiency syndromes (1999), 2007-05, Vol.45 (1), p.34-42

2007

Volltextzugriff (PDF)

Risk factors for advanced liver fibrosis in HIV-infected individuals: role of antiretroviral drugs and insulin resistance

Journal of viral hepatitis, 2011-01, Vol.18 (1), p.11-16

2011

Volltextzugriff (PDF)

Noncirrhotic Portal Hypertension in Perinatally HIV-infected Adolescents Treated With Didanosine-containing Antiretroviral Regimens in Childhood

The Pediatric infectious disease journal, 2016-08, Vol.35 (8), p.e248-e252

2016

Volltextzugriff (PDF)

Noncirrhotic portal hypertension in HIV-infected patients: unique clinical and pathological findings

AIDS (London), 2010-05, Vol.24 (8), p.1171-1176

2010

Volltextzugriff (PDF)

Results of a phase 2 clinical trial at 48 weeks (AI424-007): a dose-ranging, safety, and efficacy comparative trial of atazanavir at three doses in combination with didanosine and stavudine in antiretroviral-naive subjects

Journal of acquired immune deficiency syndromes (1999), 2003-01, Vol.32 (1), p.18-29

2003

Volltextzugriff (PDF)

Risk factors and outcome of HIV-associated idiopathic noncirrhotic portal hypertension

Alimentary pharmacology & therapeutics, 2012-11, Vol.36 (9), p.875-885

2012

Volltextzugriff (PDF)

Nucleoside Analogues and Mitochondrial Toxicity

Clinical infectious diseases, 2004-04, Vol.38 (8), p.e79-e80

2004

Volltextzugriff (PDF)

A Randomized Factorial Trial Comparing 4 Treatment Regimens in Treatment-Naive HIV-Infected Persons with AIDS and/or a CD4 Cell Count <200 Cells/μL in South Africa

The Journal of infectious diseases, 2010-11, Vol.202 (10), p.1529-1537

2010

Volltextzugriff (PDF)

A farewell to didanosine: harm reduction and cost savings by eliminating use of didanosine

International journal of STD & AIDS, 2015-10, Vol.26 (12), p.903-906

2015

Volltextzugriff (PDF)

Depletion of mitochondrial DNA in liver under antiretroviral therapy with didanosine, stavudine, or zalcitabine

Hepatology (Baltimore, Md.), 2004-02, Vol.39 (2), p.311-317

2004

Volltextzugriff (PDF)

1 – 25 von 615

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(497)
Mit Volltextzugriff
(378)

Publikationsform

Artikel
(609)
magazinearticle
(6)

Sprache

3 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Humans
(603)
Didanosine - Adverse Effects
(462)
Hiv Infections - Drug Therapy
(432)
Science & Technology
(403)
Life Sciences & Biomedicine
(402)
Aids/hiv
(362)
Male
(359)
Female
(321)
Didanosine - Therapeutic Use
(315)
Adult
(303)
Anti-Hiv Agents - Adverse Effects
(262)
Biological And Medical Sciences
(249)
Medical Sciences
(249)
Infectious Diseases
(236)
Drug Therapy, Combination
(213)
Didanosine - Administration & Dosage
(192)
Middle Aged
(183)
Pharmacology. Drug Treatments
(177)
Immunology
(162)
Human Immunodeficiency Virus
(160)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Use of nucleoside reverse transcriptase inhibitors and risk of myocardial infarction in HIV-infected patients enrolled in the D:A:D study: a multi-cohort collaboration

Prior exposure to thymidine analogs and didanosine is associated with long-lasting alterations in adipose tissue distribution and cardiovascular risk factors

Ten-year diabetes incidence in 1046 HIV-infected patients started on a combination antiretroviral treatment

Liver fibrosis in HIV-infected individuals on long-term antiretroviral therapy: associated with immune activation, immunodeficiency and prior use of didanosine

PREVALENCE OF DIDANOSINE-RELATED RETINAL TOXICITY AT AN URBAN ACADEMIC CENTER AS DIAGNOSED WITH ULTRA-WIDEFIELD IMAGING

Pericardial Adipose Tissue Volume Is Independently Associated With Human Immunodeficiency Virus Status and Prior Use of Stavudine, Didanosine, or Indinavir

Metabolic events in HIV-infected patients using abacavir are associated with erythrocyte inosine triphosphatase activity

New-onset diabetes in HIV-treated adults: predictors, long-term renal and cardiovascular outcomes

Tenofovir renal toxicity targets mitochondria of renal proximal tubules

DIDANOSINE RETINAL TOXICITY

Risk of cancer in children exposed to didanosine in utero

Epidemiology and factors associated with peripheral neuropathy among HIV infected patients in Gondar, Ethiopia: A cross-sectional study

Association of Noncirrhotic Portal Hypertension in HIV-Infected Persons and Antiretroviral Therapy with Didanosine: A Nested Case-Control Study

Impact of NRTIs on lipid levels among a large HIV-infected cohort initiating antiretroviral therapy in clinical care

Severe liver disease associated with prolonged exposure to antiretroviral drugs

Association of serum lipid levels with HIV serostatus, specific antiretroviral agents, and treatment regimens

Risk factors for advanced liver fibrosis in HIV-infected individuals: role of antiretroviral drugs and insulin resistance

Noncirrhotic Portal Hypertension in Perinatally HIV-infected Adolescents Treated With Didanosine-containing Antiretroviral Regimens in Childhood

Noncirrhotic portal hypertension in HIV-infected patients: unique clinical and pathological findings

Results of a phase 2 clinical trial at 48 weeks (AI424-007): a dose-ranging, safety, and efficacy comparative trial of atazanavir at three doses in combination with didanosine and stavudine in antiretroviral-naive subjects

Risk factors and outcome of HIV-associated idiopathic noncirrhotic portal hypertension

Nucleoside Analogues and Mitochondrial Toxicity

A Randomized Factorial Trial Comparing 4 Treatment Regimens in Treatment-Naive HIV-Infected Persons with AIDS and/or a CD4 Cell Count <200 Cells/μL in South Africa

A farewell to didanosine: harm reduction and cost savings by eliminating use of didanosine

Depletion of mitochondrial DNA in liver under antiretroviral therapy with didanosine, stavudine, or zalcitabine

Suchergebnisse filtern